UNITEDHEALTH GROUP INC
UNITEDHEALTH GROUP INC (UNH) Stock News
The latest UNH headlines and market coverage — 6 recent stories, updated throughout the day.
- Zacks Investment Research·
UNH vs. MOH: Which Managed Care Stock Looks More Attractive?
UnitedHealth Group (UNH) and Molina Healthcare (MOH) are compared as investment options in the managed care sector. UNH benefits from diversification through its Optum platform, improving profitability, and a stronger balance sheet, but faces membership pressure. MOH offers a focused recovery story with stabilizing Medicaid economics and growth in Medicare dual-eligible plans, commanding a higher valuation. Despite UNH's operational strengths, MOH is rated as the more attractive investment due to stronger projected earnings rebound, earning a Zacks Rank #1 (Strong Buy) versus UNH's Rank #2 (Buy).
- Zacks Investment Research·
Is UnitedHealth (UNH) a Buy as Wall Street Analysts Look Optimistic?
UnitedHealth Group (UNH) has an average brokerage recommendation of 1.54 (Strong Buy/Buy) from 27 firms, with 66.7% Strong Buy ratings. However, the article cautions that brokerage recommendations often carry positive bias due to vested interests. The company's Zacks Rank #2 (Buy) rating is based on earnings estimate revisions, with consensus estimates increasing 0.7% over the past month to $19.85, suggesting analyst optimism about the company's earnings prospects.
- Zacks Investment Research·Neutral
UnitedHealth Group (UNH) Stock Drops Despite Market Gains: Important Facts to Note
UnitedHealth Group stock fell 2.37% to $379.09, underperforming broader market gains. Despite the recent decline, the company maintains a Zacks Rank #2 (Buy) rating with projected EPS growth of 38.01% for the upcoming quarter. UNH trades at a Forward P/E of 19.59, below its industry average of 22.75, and the Medical - HMOs industry ranks in the top 13% of all industries.
- Zacks Investment Research·
Brokers Suggest Investing in UnitedHealth (UNH): Read This Before Placing a Bet
UnitedHealth Group (UNH) has an average brokerage recommendation of 1.46 (Strong Buy/Buy) from 27 firms, with 70.4% Strong Buy ratings. However, the article cautions that brokerage recommendations often carry positive bias due to vested interests. UNH received a Zacks Rank #2 (Buy) rating based on earnings estimate revisions, with consensus estimates increasing 0.6% over the past month to $19.82, suggesting analyst optimism about the company's earnings prospects.
- Zacks Investment Research·
CVS vs. UNH: Which Health Insurance Stock Has More Upside Now?
UnitedHealth Group (UNH) emerges as the stronger investment choice compared to CVS Health (CVS), driven by improving results across UnitedHealthcare and Optum divisions, strong operating cash flows, and more attractive valuation. While CVS shows progress with Aetna margin recovery and pharmacy momentum, it faces 2027 headwinds from Caremark's 340B business challenges and expected membership decline. UNH trades at a 35% discount to its historical valuation multiple and has delivered stronger six-month returns.
- The Motley Fool·
Don't Buy UnitedHealth Group (UNH) Stock Before Reading This
While UnitedHealth Group operates in the growing healthcare industry and has strong long-term performance, the article advises caution due to slow recent growth (2% revenue growth), ongoing DOJ investigations into Medicare billing practices, claims denial lawsuits, and challenges in its Medicare Advantage program forcing membership reductions. Despite AI investments and attractive valuation metrics, these headwinds make it a less compelling investment opportunity.